Important: New Login Process
We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.
- If your organization uses Single Sign-On (SSO), you will be redirected to your company's login portal.
- If you log in with a username and password, you will be prompted to set a new password before accessing your account.
Go to the Login Page to get started.
We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.
- Company Profiles
- Target Profiles
- Product Profiles
Explore BCIQ profiles by entering a company name.
University of Texas Health Science Center
Headquarters: San Antonio, TX, United States of America
Website: http://uthscsa.edu
Year Founded: 1959
Status: Non-biopharma
Biopharma related deals can be found by searching the organization's name in the Deals Module.
BioCentury | Jan 28, 2025
Distillery Therapeutics
Monoclonal antibodies blocking malaria binding to host EPCR
BioCentury | Aug 27, 2024
Management Tracks
Patel joins Sana as EVP, CSO
Plus: Ian Clements named CFO of Marea, new role at BII for Soni and more
BioCentury | Jun 29, 2024
Discovery & Translation
Science Spotlight: Microglial transplantation for ALSP, AlaMab’s osteosarcoma mAb and more
BioCentury’s roundup of translational innovations
BioCentury | Apr 9, 2024
Discovery & Translation
AACR brings new modalities, new targets to glioblastoma
BioCentury identifies new CAR T cell designs, ADCs and other modalities, plus 37 preclinical targets for
BioCentury | Oct 1, 2021
Distillery Therapeutics
Targeting the EFR3A-PI4KA axis to increase KRAS inhibitor sensitivity
BioCentury | Apr 8, 2021
Product Development
Next-generation drug conjugates in the spotlight at AACR
New ADC targets, structures and functionalities fill AACR21 abstracts
Items per page:
1 - 10 of 90